Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-09 · accession 0001415889-25-016722 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Tessari Eben | COO | S - Sale+OE | $30.48 | -70.9K | 72.4K | -49% | -$2.16M |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Tessari Eben | COO | M - OptEx | $10.36 | +70.9K | 82.7K | +600% | +$734.2K |
| DM | 2025-06-11 | 2025-06-09+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -70.9K | 84.0K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-06-09 | S | D | 10,319 | $30.38 | 72,363 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.42. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-06-10 | M | A | 15,506 | $10.36 | 87,869 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-06-11 | S | D | 45,042 | $30.51 | 72,363 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.69. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2025-06-11 | M | A | 45,042 | $10.36 | 117,405 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-06-10 | S | D | 15,506 | $30.46 | 72,363 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.36 and $30.64. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-06-09 | M | A | 10,319 | $10.36 | 82,682 | D | — | — | |
| 7 | Derivative | Share Option | 2025-06-09 | M | D | 10,319 | $0.00 | 99,476 | D | $10.36 · — to 2028-02-29 | 10,319 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2025-06-11 | M | D | 45,042 | $0.00 | 38,928 | D | $10.36 · — to 2028-02-29 | 45,042 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-06-10 | M | D | 15,506 | $0.00 | 83,970 | D | $10.36 · — to 2028-02-29 | 15,506 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |